STADA Arzneimittel AG - M&A Activity 2017

News Details

Corporate | 25 February 2017 11:48

STADA conducts structured and open bidding process with all interested parties

DGAP-News: STADA Arzneimittel AG / Key word(s): Miscellaneous

25.02.2017 / 11:48

The issuer is solely responsible for the content of this announcement.

Investor News

STADA conducts structured and open bidding process with all interested parties

Bad Vilbel, February 25, 2017 – This weekend, the Executive and Supervisory Boards of STADA Arzneimittel AG have converted the ongoing open-minded talks with all interested parties started on 13 February into a structured bidding process. The transparent and fair process which is open to further interested parties ensures that all potential bidders receive the same level of information and will have the same opportunity to present their plans for STADA. For this purpose, a data room has been established and the potential bidders – three to date – have been invited to conduct multistage due diligence.

In the interest of all shareholders and stakeholders of the Company, further potential for value enhancement shall be presented in this process in order to be reflected in possible offer prices. Moreover, the value of the strategic concepts of the interested parties as well as their willingness to grant protective mechanisms for stakeholders will also be examined. The Executive and Supervisory Boards intend to conduct a thorough process that will be finalized efficiently to the best interest of the Company. STADA will keep the capital market regularly updated on tangible developments.

Additional information for analysts and investors:

STADA Arzneimittel AG / Investor Relations / Stadastraße 2-18 / 61118 Bad Vilbel – Germany /

Tel.: +49 (0) 6101 603-113 / Fax: +49 (0) 6101 603-215 / E-mail: [email protected]

Or visit us in the Internet at www.stada.com .

25.02.2017 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de


Language:	English
Company:	STADA Arzneimittel AG
	Stadastraße 2-18
	61118 Bad Vilbel
	Germany
Phone:	+49 (0)6101 603- 113
Fax:	+49 (0)6101 603- 506
E-mail:	[email protected]
Internet:	www.stada.de
ISIN:	DE0007251803, DE0007251845,
WKN:	725180, 725184,
Indices:	MDAX
Listed:	Regulated Market in Dusseldorf, Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange